NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.350
-0.010 (-0.42%)
Nov 21, 2024, 3:59 PM EST - Market closed
NeuroBo Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 20 | 18 | 14 | 32 | 86 | 9,492 | |
| Market Cap Growth | 47.07% | 31.75% | -58.04% | -62.38% | -99.09% | - | |
| Enterprise Value | -1 | -8 | 7 | 26 | 74 | 9,508 | |
| Last Close Price | 2.40 | 3.70 | 5.74 | 292.80 | 1260.00 | 2100.00 | |
| PB Ratio | 1.60 | 1.07 | 0.63 | 2.22 | 11.97 | 772.21 | |
| P/TBV Ratio | 2.08 | 1.07 | 0.63 | 2.22 | 11.97 | 772.21 | |
| Debt / Equity Ratio | 0.01 | 0.01 | - | 0.00 | 0.01 | 0.01 | |
| Quick Ratio | 2.38 | 3.76 | 2.83 | 7.60 | 2.73 | 6.68 | |
| Current Ratio | 2.41 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | |
| Return on Equity (ROE) | -160.76% | -64.89% | -76.85% | -140.22% | -304.47% | -270.59% | |
| Return on Assets (ROA) | -74.35% | -35.26% | -28.36% | -68.87% | -60.82% | -54.85% | |
| Return on Capital (ROIC) | -103.55% | -51.39% | -39.19% | -87.06% | -78.51% | -62.66% | |
| Earnings Yield | -134.12% | -69.53% | -102.60% | -47.11% | -34.41% | -0.22% | |
| FCF Yield | -109.74% | -60.49% | -86.04% | -46.66% | -12.49% | -0.08% | |
| Buyback Yield / Dilution | -60.13% | -1476.33% | -233.62% | -42.70% | -210.43% | -22.88% | |
| Total Shareholder Return | -60.13% | -1476.33% | -233.62% | -42.70% | -210.43% | -22.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.